{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:46:22Z","timestamp":1764783982171},"reference-count":41,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.3892\/mmr.2017.6773","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T10:43:48Z","timestamp":1497437028000},"page":"1826-1836","source":"Crossref","is-referenced-by-count":15,"title":["Sorafenib controls the epithelial-mesenchymal transition of ovarian cancer cells via EGF and the CD44-HA signaling pathway in a cell type-dependent manner"],"prefix":"10.3892","volume":"16","author":[{"given":"Ga Bin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Suk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"key20180108004609_b1-mmr-16-02-1826","first-page":"45","article-title":"Tumor heterogeneity in metastasis","volume":"212","author":"Heppner","year":"1986","journal-title":"Prog Clin Biol Res"},{"key":"key20180108004609_b2-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180108004609_b3-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/gyno.1997.4890","article-title":"Analysis of failures after negative second-look in patients with advanced ovarian cancer: An Italian multicenter study","volume":"68","author":"Gadducci","year":"1998","journal-title":"Gynecol Oncol"},{"key":"key20180108004609_b4-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000101307","article-title":"Epithelial-mesenchymal transition in ovarian cancer progression: A crucial role for the endothelin axis","volume":"185","author":"Bagnato","year":"2007","journal-title":"Cells Tissues Organs"},{"key":"key20180108004609_b5-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignancies","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180108004609_b6-mmr-16-02-1826","first-page":"255","article-title":"Ovarian surface epithelium: Biology, endocrinology and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"key20180108004609_b7-mmr-16-02-1826","first-page":"232","article-title":"Clinical implications of the ErbB\/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer","volume":"1785","author":"Lafky","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key20180108004609_b8-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00109-006-0054-4","article-title":"Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma","volume":"84","author":"Lassus","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"key20180108004609_b9-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1349-7006.2004.tb03179.x","article-title":"Mechanism and biological significance of CD44 cleavage","volume":"95","author":"Nagano","year":"2004","journal-title":"Cancer Sci"},{"key":"key20180108004609_b10-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"22513","DOI":"10.1074\/jbc.M708319200","article-title":"CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase and MMP-2","volume":"283","author":"Kim","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180108004609_b11-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/BJ20050582","article-title":"Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10","volume":"39","author":"Murai","year":"2006","journal-title":"Biochem J"},{"key":"key20180108004609_b12-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.yexcr.2006.11.016","article-title":"EGF AND TGF-alpha motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms","volume":"313","author":"Ellis","year":"2007","journal-title":"Exp Cell Res"},{"key":"key20180108004609_b13-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M113.497685","article-title":"CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness","volume":"288","author":"Grass","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180108004609_b14-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/0008-5472.CAN-11-1831","article-title":"ERK1\/2 regulation of CD44 modulates oral cancer aggressiveness","volume":"72","author":"Judd","year":"2012","journal-title":"Cancer Res"},{"key":"key20180108004609_b15-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-3-8","article-title":"From basic research to clinical development of MEK1\/2 inhibitors for cancer therapy","volume":"3","author":"Fr\u00e9min","year":"2010","journal-title":"J Hematol Oncol"},{"key":"key20180108004609_b16-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43\u20139006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108004609_b17-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"e64954","DOI":"10.1371\/journal.pone.0064954","article-title":"Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"key20180108004609_b18-mmr-16-02-1826","first-page":"891","article-title":"Enhanced c-erbB-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A","volume":"53","author":"Yu","year":"1993","journal-title":"Cancer Res"},{"key":"key20180108004609_b19-mmr-16-02-1826","first-page":"3668","article-title":"Comparative properties of five human ovarian adenocarcinoma cell lines","volume":"45","author":"Buick","year":"1985","journal-title":"Cancer Res"},{"key":"key20180108004609_b20-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1160\/TH04-08-0536","article-title":"Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression","volume":"93","author":"Yan","year":"2005","journal-title":"Thromb Haemost"},{"key":"key20180108004609_b21-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/0008-5472.CAN-03-2832","article-title":"Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production","volume":"64","author":"Marieb","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108004609_b22-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drup.2008.04.002","article-title":"Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance","volume":"11","author":"Toole","year":"2008","journal-title":"Drug Resist Updat"},{"key":"key20180108004609_b23-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"e44071","DOI":"10.1371\/journal.pone.0044071","article-title":"A CD44high\/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment","volume":"7","author":"La Fleur","year":"2012","journal-title":"PLoS One"},{"key":"key20180108004609_b24-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharmthera.2004.01.002","article-title":"Signaling through the epidermal growth factor receptor during the development of malignancy","volume":"102","author":"Grandis","year":"2004","journal-title":"Pharmacol Ther"},{"key":"key20180108004609_b25-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1158\/0008-5472.CAN-04-0202","article-title":"Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44","volume":"64","author":"Kim","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108004609_b26-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"24381","DOI":"10.1074\/jbc.M602694200","article-title":"Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy","volume":"281","author":"Cook","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180108004609_b27-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1073\/pnas.0407378102","article-title":"RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy","volume":"101","author":"Nedvetzki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108004609_b28-mmr-16-02-1826","first-page":"839","article-title":"Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells","volume":"27","author":"Kim","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180108004609_b29-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1177\/002215549904701209","article-title":"Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions","volume":"47","author":"Caudroy","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"key20180108004609_b30-mmr-16-02-1826","first-page":"157","article-title":"Cancer-related issues of CD147","volume":"7","author":"Weidle","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"key20180108004609_b31-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","article-title":"Hyaluronan-CD44 interactions in cancer: Paradoxes and possibilities","volume":"15","author":"Toole","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108004609_b32-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijc.10683","article-title":"Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors","volume":"102","author":"Jacobson","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180108004609_b33-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1158\/0008-5472.CAN-09-1950","article-title":"Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression","volume":"69","author":"Chen","year":"2009","journal-title":"Cancer Res"},{"key":"key20180108004609_b34-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-3163-5-2","article-title":"Expression of hyaluronan in human tumor progression","volume":"5","author":"Boregowda","year":"2006","journal-title":"J Carcinog"},{"key":"key20180108004609_b35-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1054\/bjoc.2001.1922","article-title":"Hyaluronan production increases the malignant properties of mesothelioma cells","volume":"85","author":"Li","year":"2001","journal-title":"Br J Cancer"},{"key":"key20180108004609_b36-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s13277-012-0369-4","article-title":"Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells","volume":"33","author":"Tamada","year":"2012","journal-title":"Tumour Biol"},{"key":"key20180108004609_b37-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1471-2407-13-476","article-title":"Chemotherapy-induced hyaluronan production: A novel chemoresistance mechanism in ovarian cancer","volume":"13","author":"Ricciardelli","year":"2013","journal-title":"BMC Cancer"},{"key":"key20180108004609_b38-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.164.4.2053","article-title":"Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells","volume":"164","author":"Fitzgerald","year":"2000","journal-title":"J Immunol"},{"key":"key20180108004609_b39-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/onc.2011.644","article-title":"Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3\u03b2 and NF-\u03baB to suppress tumor cell growth","volume":"31","author":"Dudgeon","year":"2012","journal-title":"Oncogene"},{"key":"key20180108004609_b40-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","article-title":"Early detection and treatment of ovarian cancer: Shifting from early stage to minimal volume of disease based on a new model of carcinogenesis","volume":"198","author":"Kurman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108004609_b41-mmr-16-02-1826","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","article-title":"Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma","volume":"90","author":"Gemignani","year":"2003","journal-title":"Gynecol Oncol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T02:13:08Z","timestamp":1569463988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,14]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.3892\/mmr.2017.6773"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6773","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}